Report Detail
Global Dry Powder Inhalation Medication Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
- RnM4580161 |
- 29 March, 2024 |
- Global |
- 110 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Dry Powder Inhalation Medication market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Dry powder inhaler (DPI), also known as inhalation powder mist, refers to the solid micronized raw material drug alone or mixed with a suitable carrier, in the form of capsules, vesicles or multi-dose storage, using a specially made dry powder for inhalation A device in which the patient actively inhales aerosolized medication into the lungs. It has decades of research history abroad, and most of the drugs currently on the market are used to treat asthma and chronic obstructive pulmonary disease.
The Global Info Research report includes an overview of the development of the Dry Powder Inhalation Medication industry chain, the market status of Asthmatic (Single Dose, Multiple Doses), COPD (Single Dose, Multiple Doses), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Dry Powder Inhalation Medication.
Regionally, the report analyzes the Dry Powder Inhalation Medication markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Dry Powder Inhalation Medication market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Dry Powder Inhalation Medication market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Dry Powder Inhalation Medication industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Single Dose, Multiple Doses).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Dry Powder Inhalation Medication market.
Regional Analysis: The report involves examining the Dry Powder Inhalation Medication market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Dry Powder Inhalation Medication market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Dry Powder Inhalation Medication:
Company Analysis: Report covers individual Dry Powder Inhalation Medication manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Dry Powder Inhalation Medication This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Asthmatic, COPD).
Technology Analysis: Report covers specific technologies relevant to Dry Powder Inhalation Medication. It assesses the current state, advancements, and potential future developments in Dry Powder Inhalation Medication areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Dry Powder Inhalation Medication market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Dry Powder Inhalation Medication market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Single Dose
Multiple Doses
Storage Type
Market segment by Application
Asthmatic
COPD
Other
Major players covered
Pharmaxis Ltd.
AstraZeneca
GSK
Novartis
Gilead Sciences
Boehringer Ingelheim
ORION CORPORATION
Teva Pharmaceuticals
TFF Pharmaceuticals Inc.
Sunovion Pharmaceuticals
Pfizer
Eli Lilly and Company
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dry Powder Inhalation Medication product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Dry Powder Inhalation Medication, with price, sales, revenue and global market share of Dry Powder Inhalation Medication from 2019 to 2024.
Chapter 3, the Dry Powder Inhalation Medication competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dry Powder Inhalation Medication breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Dry Powder Inhalation Medication market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dry Powder Inhalation Medication.
Chapter 14 and 15, to describe Dry Powder Inhalation Medication sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Dry Powder Inhalation Medication
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Dry Powder Inhalation Medication Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Single Dose
- 1.3.3 Multiple Doses
- 1.3.4 Storage Type
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Dry Powder Inhalation Medication Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Asthmatic
- 1.4.3 COPD
- 1.4.4 Other
- 1.5 Global Dry Powder Inhalation Medication Market Size & Forecast
- 1.5.1 Global Dry Powder Inhalation Medication Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Dry Powder Inhalation Medication Sales Quantity (2019-2030)
- 1.5.3 Global Dry Powder Inhalation Medication Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 Pharmaxis Ltd.
- 2.1.1 Pharmaxis Ltd. Details
- 2.1.2 Pharmaxis Ltd. Major Business
- 2.1.3 Pharmaxis Ltd. Dry Powder Inhalation Medication Product and Services
- 2.1.4 Pharmaxis Ltd. Dry Powder Inhalation Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Pharmaxis Ltd. Recent Developments/Updates
- 2.2 AstraZeneca
- 2.2.1 AstraZeneca Details
- 2.2.2 AstraZeneca Major Business
- 2.2.3 AstraZeneca Dry Powder Inhalation Medication Product and Services
- 2.2.4 AstraZeneca Dry Powder Inhalation Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 AstraZeneca Recent Developments/Updates
- 2.3 GSK
- 2.3.1 GSK Details
- 2.3.2 GSK Major Business
- 2.3.3 GSK Dry Powder Inhalation Medication Product and Services
- 2.3.4 GSK Dry Powder Inhalation Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 GSK Recent Developments/Updates
- 2.4 Novartis
- 2.4.1 Novartis Details
- 2.4.2 Novartis Major Business
- 2.4.3 Novartis Dry Powder Inhalation Medication Product and Services
- 2.4.4 Novartis Dry Powder Inhalation Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Novartis Recent Developments/Updates
- 2.5 Gilead Sciences
- 2.5.1 Gilead Sciences Details
- 2.5.2 Gilead Sciences Major Business
- 2.5.3 Gilead Sciences Dry Powder Inhalation Medication Product and Services
- 2.5.4 Gilead Sciences Dry Powder Inhalation Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Gilead Sciences Recent Developments/Updates
- 2.6 Boehringer Ingelheim
- 2.6.1 Boehringer Ingelheim Details
- 2.6.2 Boehringer Ingelheim Major Business
- 2.6.3 Boehringer Ingelheim Dry Powder Inhalation Medication Product and Services
- 2.6.4 Boehringer Ingelheim Dry Powder Inhalation Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Boehringer Ingelheim Recent Developments/Updates
- 2.7 ORION CORPORATION
- 2.7.1 ORION CORPORATION Details
- 2.7.2 ORION CORPORATION Major Business
- 2.7.3 ORION CORPORATION Dry Powder Inhalation Medication Product and Services
- 2.7.4 ORION CORPORATION Dry Powder Inhalation Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 ORION CORPORATION Recent Developments/Updates
- 2.8 Teva Pharmaceuticals
- 2.8.1 Teva Pharmaceuticals Details
- 2.8.2 Teva Pharmaceuticals Major Business
- 2.8.3 Teva Pharmaceuticals Dry Powder Inhalation Medication Product and Services
- 2.8.4 Teva Pharmaceuticals Dry Powder Inhalation Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Teva Pharmaceuticals Recent Developments/Updates
- 2.9 TFF Pharmaceuticals Inc.
- 2.9.1 TFF Pharmaceuticals Inc. Details
- 2.9.2 TFF Pharmaceuticals Inc. Major Business
- 2.9.3 TFF Pharmaceuticals Inc. Dry Powder Inhalation Medication Product and Services
- 2.9.4 TFF Pharmaceuticals Inc. Dry Powder Inhalation Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 TFF Pharmaceuticals Inc. Recent Developments/Updates
- 2.10 Sunovion Pharmaceuticals
- 2.10.1 Sunovion Pharmaceuticals Details
- 2.10.2 Sunovion Pharmaceuticals Major Business
- 2.10.3 Sunovion Pharmaceuticals Dry Powder Inhalation Medication Product and Services
- 2.10.4 Sunovion Pharmaceuticals Dry Powder Inhalation Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 Sunovion Pharmaceuticals Recent Developments/Updates
- 2.11 Pfizer
- 2.11.1 Pfizer Details
- 2.11.2 Pfizer Major Business
- 2.11.3 Pfizer Dry Powder Inhalation Medication Product and Services
- 2.11.4 Pfizer Dry Powder Inhalation Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.11.5 Pfizer Recent Developments/Updates
- 2.12 Eli Lilly and Company
- 2.12.1 Eli Lilly and Company Details
- 2.12.2 Eli Lilly and Company Major Business
- 2.12.3 Eli Lilly and Company Dry Powder Inhalation Medication Product and Services
- 2.12.4 Eli Lilly and Company Dry Powder Inhalation Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.12.5 Eli Lilly and Company Recent Developments/Updates
3 Competitive Environment: Dry Powder Inhalation Medication by Manufacturer
- 3.1 Global Dry Powder Inhalation Medication Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Dry Powder Inhalation Medication Revenue by Manufacturer (2019-2024)
- 3.3 Global Dry Powder Inhalation Medication Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Dry Powder Inhalation Medication by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Dry Powder Inhalation Medication Manufacturer Market Share in 2023
- 3.4.2 Top 6 Dry Powder Inhalation Medication Manufacturer Market Share in 2023
- 3.5 Dry Powder Inhalation Medication Market: Overall Company Footprint Analysis
- 3.5.1 Dry Powder Inhalation Medication Market: Region Footprint
- 3.5.2 Dry Powder Inhalation Medication Market: Company Product Type Footprint
- 3.5.3 Dry Powder Inhalation Medication Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Dry Powder Inhalation Medication Market Size by Region
- 4.1.1 Global Dry Powder Inhalation Medication Sales Quantity by Region (2019-2030)
- 4.1.2 Global Dry Powder Inhalation Medication Consumption Value by Region (2019-2030)
- 4.1.3 Global Dry Powder Inhalation Medication Average Price by Region (2019-2030)
- 4.2 North America Dry Powder Inhalation Medication Consumption Value (2019-2030)
- 4.3 Europe Dry Powder Inhalation Medication Consumption Value (2019-2030)
- 4.4 Asia-Pacific Dry Powder Inhalation Medication Consumption Value (2019-2030)
- 4.5 South America Dry Powder Inhalation Medication Consumption Value (2019-2030)
- 4.6 Middle East and Africa Dry Powder Inhalation Medication Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Dry Powder Inhalation Medication Sales Quantity by Type (2019-2030)
- 5.2 Global Dry Powder Inhalation Medication Consumption Value by Type (2019-2030)
- 5.3 Global Dry Powder Inhalation Medication Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Dry Powder Inhalation Medication Sales Quantity by Application (2019-2030)
- 6.2 Global Dry Powder Inhalation Medication Consumption Value by Application (2019-2030)
- 6.3 Global Dry Powder Inhalation Medication Average Price by Application (2019-2030)
7 North America
- 7.1 North America Dry Powder Inhalation Medication Sales Quantity by Type (2019-2030)
- 7.2 North America Dry Powder Inhalation Medication Sales Quantity by Application (2019-2030)
- 7.3 North America Dry Powder Inhalation Medication Market Size by Country
- 7.3.1 North America Dry Powder Inhalation Medication Sales Quantity by Country (2019-2030)
- 7.3.2 North America Dry Powder Inhalation Medication Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Dry Powder Inhalation Medication Sales Quantity by Type (2019-2030)
- 8.2 Europe Dry Powder Inhalation Medication Sales Quantity by Application (2019-2030)
- 8.3 Europe Dry Powder Inhalation Medication Market Size by Country
- 8.3.1 Europe Dry Powder Inhalation Medication Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Dry Powder Inhalation Medication Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Dry Powder Inhalation Medication Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Dry Powder Inhalation Medication Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Dry Powder Inhalation Medication Market Size by Region
- 9.3.1 Asia-Pacific Dry Powder Inhalation Medication Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Dry Powder Inhalation Medication Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Dry Powder Inhalation Medication Sales Quantity by Type (2019-2030)
- 10.2 South America Dry Powder Inhalation Medication Sales Quantity by Application (2019-2030)
- 10.3 South America Dry Powder Inhalation Medication Market Size by Country
- 10.3.1 South America Dry Powder Inhalation Medication Sales Quantity by Country (2019-2030)
- 10.3.2 South America Dry Powder Inhalation Medication Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Dry Powder Inhalation Medication Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Dry Powder Inhalation Medication Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Dry Powder Inhalation Medication Market Size by Country
- 11.3.1 Middle East & Africa Dry Powder Inhalation Medication Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Dry Powder Inhalation Medication Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Dry Powder Inhalation Medication Market Drivers
- 12.2 Dry Powder Inhalation Medication Market Restraints
- 12.3 Dry Powder Inhalation Medication Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Dry Powder Inhalation Medication and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Dry Powder Inhalation Medication
- 13.3 Dry Powder Inhalation Medication Production Process
- 13.4 Dry Powder Inhalation Medication Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Dry Powder Inhalation Medication Typical Distributors
- 14.3 Dry Powder Inhalation Medication Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Dry Powder Inhalation Medication. Industry analysis & Market Report on Dry Powder Inhalation Medication is a syndicated market report, published as Global Dry Powder Inhalation Medication Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Dry Powder Inhalation Medication market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
